Streetbeat News

Regulatory

CTSO

Cytosorbents has completed enrollment in the pivotal Safe and Timely Antithrombotic Removal – Ticagrelor trial. The trial is evaluating the ability of DrugSorb-ATR to reduce perioperative bleeding in patients undergoing cardiothoracic surgery on Ticagrelor.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 11:23 am

BIIB

Biogen's shares resumed trading and rose 2.5% following the FDA's approval of its Alzheimer's drug, Leqembi, on Thursday.

Portfolio Pulse from Charles Gross

July 07, 2023 | 11:16 am

SPY

VGK

NATO leaders, at the Vilnius Summit, will reaffirm that Ukraine will become a member of NATO and discuss how to bring Ukraine closer to this goal, according to NATO's Stoltenberg.

Portfolio Pulse from Charles Gross

July 07, 2023 | 11:07 am

LLY

NVO

Novo Nordisk has filed lawsuits against TruLife Pharmacy, Brooksville Pharmaceuticals, and WellHealth Inc, accusing them of illegally selling products containing semaglutide, an active ingredient in Novo Nordisk's weight loss and diabetes drugs. The company argues that these actions create an unfair competitive advantage and jeopardize patient safety. The global weight-loss therapies market is expected to reach $100 billion in the next decade, with Novo Nordisk and Eli Lilly as the primary beneficiaries.

Portfolio Pulse from Vandana Singh

July 07, 2023 | 11:03 am

BABA

Alibaba Group Holding Limited (NYSE:BABA) stock is trading higher amid reports of China looking to end its regulatory overhaul on fintech affiliate Ant Group with a penalty of $1.1 billion. The penalty will help Ant Group secure a financial holding company license and revive its listing plans. Alibaba also announced that its AI image generator will be initially available to enterprise customers in beta form.

Portfolio Pulse from Anusuya Lahiri

July 07, 2023 | 10:33 am

BABA

Alibaba Group Holding's stock is trading higher following reports that China is planning to conclude its regulatory overhaul on fintech affiliate Ant Group with a penalty of at least 8 billion yuan ($1.1 billion) by Friday.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:31 am

YJ

Yunji has regained compliance with Nasdaq's minimum bid price requirement. The closing bid price of the company's ADSs has been at $1.00 per ADS or greater for 10 consecutive business days from June 20, 2023, through July 3, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:03 am

FXI

SPY

U.S. Treasury Secretary Yellen met with Chinese Premier Li in Beijing, emphasizing that the U.S. seeks healthy competition, not a winner-take-all approach. Yellen also stated that the U.S. and China should not allow disagreements to lead to misunderstandings that worsen bilateral ties.

Portfolio Pulse from Charles Gross

July 07, 2023 | 9:11 am

EWH

FXI

SPY

U.S. inspectors have started a new round of routine checks on audits of Wall Street-listed Chinese companies in Hong Kong, according to Reuters. This could potentially impact the performance of ETFs like EWH, FXI, and SPY.

Portfolio Pulse from Charles Gross

July 07, 2023 | 9:04 am

BABA

FXI

China is set to conclude Ant Group's regulatory overhaul with a fine of at least $1.1 billion, according to a Reuters report. This marks the end of the company's years-long regulatory overhaul.

Portfolio Pulse from Charles Gross

July 07, 2023 | 8:52 am